Insights on ErbB glycosylation – contributions to precision oncology
- 6 March 2022
- journal article
- review article
- Published by Elsevier in Trends in Cancer
- Vol. 8 (6) , 448-455
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund
- Fundação para a Ciência e a Tecnologia (PTDC/MEC-ONC/0491/2021)
This publication has 49 references indexed in Scilit:
- Targeting the ERBB family in cancer: couples therapyNature Reviews Cancer, 2013
- Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cellsProceedings of the National Academy of Sciences, 2011
- Specific posttranslational modification regulates early events in mammary carcinoma formationProceedings of the National Academy of Sciences, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- N-glycan of ErbB family plays a crucial role in dimer formation and tumor promotionBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptorProceedings of the National Academy of Sciences, 2006
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myelomaOncogene, 2006
- Functional Effects of Glycosylation at Asn-579 of the Epidermal Growth Factor ReceptorBiochemistry, 2005
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005